key: cord-0742271-1ycfram4
authors: Ozbey, Rafet; Algan, Mehmet Fatih
title: Acro‐ischemic lesions in COVID‐19 patients: A case series
date: 2022-03-14
journal: J Cosmet Dermatol
DOI: 10.1111/jocd.14893
sha: e4eb4f9140029f38bf8a89f4bfe1280add73cba1
doc_id: 742271
cord_uid: 1ycfram4

COVID‐19 is a systemic disease characterized by vascular damage, increased inflammation, and hypercoagulability. Acral ischemic lesions occur as a result of increased inflammation and cutaneous thrombosis. Skin lesions can sometimes be the only symptom of COVID‐19. In this respect, recognizing acro‐ischemic lesions, which are skin lesions, may help in the early diagnosis of the disease and in predicting the prognosis. In patients with skin lesions without typical symptoms, the diagnosis of COVID‐19 should be kept in mind. Herein, we describe five patients affected by COVID‐19 which developed acro‐ischemic lesions.

In December 2019, unexplained viral pneumonia cases began to be reported in Wuhan province of China. The agent was identified as a new coronavirus pathogen (SARS-CoV-2) and the disease was named Coronavirus disease 2019 . In March 2020, the pandemic was declared by World Health Organization. 1, 2 This rapidly spreading deadly virus has affected the health system in many countries adversely. Healthcare professionals had to fight with many complications caused by the disease while trying to keep people affected by the pandemic alive.

Although COVID-19 was first defined as a respiratory problem, it was later understood to be a systemic disease. 3 The disease symptoms cover a wide range. While it may be asymptomatic or like flu, it may also progress with a clinic that leads to multiple organ failure. 4, 5 The primary targets of the virus are vascular endothelium cells, pneumocytes, and immune cells. 6 Endothelial function is impaired by the infection and the inflammation of the endothelium with SARS-COV-2. The resulting endothelial dysfunction results in the loss of fibrinolytic feature and disposition to thrombosis. 7, 8 Microand macro-thrombosis in vessels may cause problems that may lead to multi-organ failure. The resulting thromboinflammation state is associated with the weight of the disease. 6 The number of studies on skin findings of COVID-19 disease is gradually increasing in literature. Although there is no consensus on naming the lesions, acral ischemic lesions seen in COVID-19 disease are grouped in two: (1) pseudo chilblain (pseudo perniosis) (2) livedo or necrosis. Pseudo chilblain is mostly seen in young people and in the late periods of the disease, and it continues for an average of 12, 7 days. It involves first the feet and then the hands. 9 Livedo or necrosis is mostly seen in patients with advanced age and comorbidity and in patients whose clinic has a severe course. It is thought that it occurs secondary to acral ischemia and microvascular occlusion that occurs as a result of the worsening in the patient's general health or coagulation anomalies that occur. It is very rare among skin lesions due to COVID-19 (6%).

In this study, we aimed to bring to literature five COVID-19 patients who developed acro-ischemic skin lesions (livedo, necrosis).

We included patients who were evaluated with acro-ischemic findings in our tertiary care hospital between March 2020 and November 2021 and whose diagnosis of COVID-19 was confirmed by RT-PCR on a nasopharyngeal swab sample. Informed consent was obtained from all our patients or relatives. Variables such as demographics, comorbidities, clinical presentations, diagnosis, and treatment data were gathered.

A 61-year-old female patient who had necrosis and pain on the fingers, painful purpuric rashes on feet and legs and occasional hemorrhagic bullae ( Figure 1A ,B,C,D) was admitted to the emergency department of our hospital on October 29, 2020. There were no features in her anamnesis other than hypertension. It was learned that she never had complaints such as fever, cough, shortness of breath and malaise before. The patient's chest computerized tomography (CT) was found to be compatible with COVID-19.

COVID-19 polymerase chain reaction (PCR) test studied from nasopharyngeal specimen was negative. Her test on November 10 was positive. The patient's wounds started from the soles of the feet and progressed to both feet and cruris. Incisional biopsy from cru- 

A 82-year-old female patient referred with complaints of fever, cough, and malaise. The patient's chest CT was found to be compatible with viral pneumonia findings. PCR test was found to be positive. The patient was using metoprolol for arrhythmia and leflunomide for rheumatoid arthritis. She was admitted to hospital on 25th day after the COVID-19 PCR test positivity with complaints of coldness and bruising in the right lower extremity. 

A 8-year-old male patient that was admitted to hospital with complaints of fever and shortness of breath was hospitalized and treated. The patient who had Down syndrome and who had been diagnosed with acute lymphocytic leukemia (ALL) for two years was using levetiracetam for seizures. The patient whose general condition worsened was intubated. Necrosis developed on the left hand second finger and distal of right first toe. (Figure 3A ,B). COVID-19

PCR test made 15 days later was found to be positive. Chest CT was found to be compatible with pneumonia. Low velocity monophasic flow was detected in bilateral radial, ulnar, posterior tibial, and dorsalis pedis arteries in Doppler USG.

A 71-year-old male patient was admitted to our hospital with complaints of fever and malaise. COVID-19 PCR test of the patient who had diabetes mellitus (DM) and chronic renal failure (CRF) was found to be positive. Chest CT was compatible with viral pneumonia. Right hand 1st, 2nd, 3 rd , and 5th finger distal phalanx tips and glans penis tips had necrosis Doppler USG was normal. Distal phalanx tips of the right hand first and second fingers were amputated and left open and the necrotic parts of the glans penis were debrided ( Figure 4A ,B,C).

A 61-year-old male patient was admitted to the hospital with com- 

We present five COVID-19 patients with acro-ischemic lesions in the hope that they may be helpful in diagnosing the disease and predicting prognosis. One of the patients was a child, the other four patients were older than 60 years of age and all of the patients had at least one comorbid disease. Except for the child patient, the patients did not have a severe clinic. All of our patients were found

to have PCR test positivity. Following the regression and disappearance of the livedoid lesions in the extremities, necrosis developed on finger tips. While all of our patients had finger/toe necrosis, one of our patients also had penile necrosis and two of our patients also had skin necrosis (Table 1) . Radiological imaging revealed signs of thrombosis in the extremity vessels, except for one patient. One of our patients had thrombosis in the right popliteal artery leading to complete occlusion (Table 1) Inflammatory markers such as C reactive protein (CRP) and procalcitonin (PCT) increased in our patients (Table 1 ). This causes microvascular damage and abnormal activation of the coagulation system, resulting in increased vascular inflammation and thrombosis. 11 Ddimer increases in our patients showed an increased tendency to coagulation (Table 1) . Thromboses can be arterial, venous, and microvascular. Although thromboses are mostly reported to be venous, arterial thromboses were found in our patients. All of our patients were given low molecular weight heparin (LMWH), which has antiinflammatory properties and anticoagulant properties and which has taken its place in routine treatment. 12, 13 However, in one study, in 90% of COVID-19 patients with thrombotic complications developed thrombosis despite the use of LMWH. Although prophylaxis is thought to decrease thrombotic events and be effective on mortality, it has been observed that it does not eliminate this risk completely. 14 Rethrombosis developed even in patients who received intense anticoagulant therapy. 15 It has been reported that LMWHs used in patients with acro-ischemia decrease D-dimer and fibrinogen levels but does not cause a change in their clinic. 16 Although LMWH was used in all our patients, no significant improvement was observed in their clinics. Our results are in parallel with the literature.

Acral ischemic lesions occur as a result of increased inflammation and cutaneous thrombosis. 17 Pernio, one of the acral ischemic lesions, occurs due to increased inflammation. However, livedoid lesions occur due to cutaneous thrombosis and may also develop as precursor lesions of COVID-19. 9,18 It is reported that acro-ischemic Others symptoms and onset day 1st day; Pain in hands and feet, bruising on finger tips, livedoid lesions on the hands ( Figure 1A) 9th day; hemorrhagic bulla on the sole of the feet ( Figure 1B ) 16th day; painful purpuric rashes on feet and legs and occasional hemorrhagic bullae (Figure 1c, Figure 1I , J) 39th day Right foot 1st and 2nd toe tips ( Figure 2C) 31st day Left hand 2nd finger ( Figure 3A )

Right foot 1st toe ( Figure 3B) 18th day Right hand 1,2,3 and 5th fingers ( Figure 4A,B) 28th day Right hand 2,3,4 and 5th fingers ( Figure 5 )

Skin necrosis 33th day Bilateral lower leg and feet (Figure 1E ,F,G,H) 45th day Right lower leg ( Figure 2A , 

PCR from nasopharyngeal swab was negative when biopsy was taken, PCR from tissue sample was negative too. Our patient did not have any complaints suggesting COVID-19 such as fever, shortness of breath, and malaise. The chest CT taken when admitted for rashes was found to have COVID-19 pneumonia findings, and the patient was found to have PCR positivity 12 days later. In both studies, the lesions showed 1 month after COVID-19-like complaints. In our patient, lesions occurred 3 days before COVID-19 diagnosis. This situation was explained in literature as that skin lesions associated with COVID-19 may occur before, during and after COVID-19 diagnosis. Almost 70% of the lesions start after COVID-19 diagnosis. 21 Consistent with the literature, 60% of our patients (3 patients) had skin lesion after diagnosis and 40% (2 patients) had skin lesion before diagnosis (Table 1) .

Skin lesions can sometimes be the only symptom of COVID-19.

In this respect, recognizing acro-ischemic lesions, which are skin lesions, may help in the early diagnosis of the disease and in predicting the prognosis. In patients with skin lesions without typical symptoms, the diagnosis of COVID-19 should be kept in mind.

The authors declare no conflict of interests.

Written informed consent was obtained from each patient for publication of this study and associated digital images.

The data that support the findings of this study are available from the corresponding author upon reasonable request.

https://orcid.org/0000-0003-0759-5003

Mehmet Fatih Algan https://orcid.org/0000-0002-7192-4695

COVID-19) Situation Report-63. World Health Organization. 2020. www.who. int/docs/defau lt-sourc e/coron aviru se/situa tionr eport s/20200 323-sitre p-63-covid -19.pdf?sfvrs n=d97cb 6dd_2

Investıgatıon of the effect of corona precautions on transmission prevention of upper respiratory tract infections and statistical comparison

Coagulopathy and thrombosis as a result of severe COVID-19 infection: a microvascular focus

Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis

Time-to-death approach in revealing chronicity and severity of COVID-19 across the world

Coagulopathy of coronavirus disease 2019

Smoking upregulates angiotensin-Converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19)

Effect of angiotensinconverting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2

Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19

COVID-19 and its implications for thrombosis and anticoagulation

COVID-19 update: Covid-19-associated coagulopathy

Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: a retrospective study

COVID-19-related aortic thrombosis: a report of four cases

Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acroischemia

Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)

A dermatologic manifestation of COVID-19: transient livedo reticularis

Acrofacial purpura and necrotic ulcerations in COVID-19: a case series from New York City

Skin manifestations of COVID-19: a worldwide review

Cutaneous manifestations of COVID-19: report of three cases and a review of literature

Penile ischaemia secondary to COVID-19: why should the dermatologist be concerned?

The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries

Cutaneous small vessel vasculitis secondary to COVID-19 infection: a case report

Leucocytoclastic vasculitis in a patient with COVID-19 with positive SARS-CoV-2 PCR in skin biopsy

Acro-ischemic lesions in COVID-19 patients: A case series